Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice
出版年份 2012 全文链接
标题
Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 86, Issue 9, Pages 5026-5038
出版商
American Society for Microbiology
发表日期
2012-03-15
DOI
10.1128/jvi.06684-11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
- (2011) Carmen E. Gomez et al. CURRENT GENE THERAPY
- Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses
- (2011) Imma Montanuy et al. FASEB JOURNAL
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors
- (2011) Esther D. Quakkelaar et al. PLoS One
- A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
- (2011) Juan García-Arriaza et al. PLoS One
- Improved NYVAC-Based Vaccine Vectors
- (2011) Karen V. Kibler et al. PLoS One
- Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
- (2011) B. J. Flynn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines
- (2011) Vinod Kumar Bhaskara Pillai et al. VACCINE
- Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7
- (2011) Leonie Unterholzner et al. PLoS Pathogens
- IFN- Receptor Signaling Regulates Memory CD8+ T Cell Differentiation
- (2010) O. Sercan et al. JOURNAL OF IMMUNOLOGY
- Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
- (2010) José Luis Nájera et al. PLoS One
- Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
- (2010) Juan García-Arriaza et al. PLoS One
- Poxvirus vector-based HIV vaccines
- (2010) Giuseppe Pantaleo et al. Current Opinion in HIV and AIDS
- The Interferon System and Vaccinia Virus Evasion Mechanisms
- (2009) Beatriz Perdiguero et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Immunization with Live Attenuated Influenza Viruses That Express Altered NS1 Proteins Results in Potent and Protective Memory CD8+ T-Cell Responses
- (2009) S. N. Mueller et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model
- (2009) Jens Wild et al. VIRAL IMMUNOLOGY
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components
- (2008) Z. Waibler et al. JOURNAL OF VIROLOGY
- Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates
- (2008) P. Mooij et al. JOURNAL OF VIROLOGY
- Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
- (2008) Matthew G. Cottingham et al. PLoS One
- EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- (2008) Pierre-Alexandre Bart et al. VACCINE
- EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
- (2008) Sheena McCormack et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search